Answers are grounded in this paper and cite their sources.
The findings suggest IV-ibuprofen may be a safer alternative to ketorolac, potentially improving patient care outcomes while reducing healthcare system burden. These results have implications for clinical practice and healthcare resource management.
No takes yet. Share an insight, caveat, or question.
Afolabi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: